University Events Calendar
16 April, 2013

Date/Time: Tuesday, 16 April 2013, 4:00 pm to 5:30 pm
Location: Robson Lecture Theatre, Eleanor Harrald Building, University of Adelaide
Cost: Free

Two internationally renowned experts share some thoughts on everything you've ever wanted to know about genetics, epigenetics and population health. This event is not to be missed.

George Davey Smith is Professor of Clinical Epidemiology at the University of Bristol, honorary professor of public health at the University of Glasgow and visiting professor at the London School of Hygiene and Tropical Medicine. He is Scientific Director of the Avon Longitudinal Study of Parents and Children (ALSPAC) and Director of the MRC Centre for Causal Analyses in Translational Epidemiology. His major research interest relates to the use of genetic epidemiology for informing understanding of the causal influence of environmentally modifiable risk factors and how social inequalities in health are generated by exposures acting over the entire lifecourse. Professor Davey Smith has also worked on HIV\AIDS prevention in Nicaragua and India and on issues around the history of epidemiology, meta-analysis, lay epidemiology and epidemiological methodology. His H index is 100, and he is an associate of the US Institute of Medicine and US National Academy of Sciences. He is co-editor of the International Journal of Epidemiology.

Caroline Relton is Professor of Genetic and Epigenetic Epidemiology at the Institute of Genetic Medicine, Newcastle University with joint appointment at the MRC Centre for Causal Analyses in Translational Epidemiology, University of Bristol, UK. Her research focuses on the determinants and consequences of epigenetic variation in human populations. The primary aim of her programme of research in is to identify novel epigenetic biomarkers, explore their causal relationship with common complex disease and pursue the translation and application of these biomarkers to clinically relevant scenarios. Her work includes investigation of the role of epigenetic mechanisms in a range of health outcomes including type 2 diabetes, obesity, cardiovascular health and dementia as well as methodological development in epigenetic epidemiology.

Contact: Professor John Lynch (email), Business: 8313 6541